Cue Biopharma (CUE) Amortizatization of Intangibles (2020 - 2025)

Cue Biopharma has reported Amortizatization of Intangibles for 5 years, with the latest figure at -$30000.0 in Q4 2025.

• Quarterly Amortizatization of Intangibles changed N/A year-over-year to -$30000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$30000.0 (changed N/A YoY) and the FY2025 annual result came in at -$212000.0, changed N/A from the prior year.
• Amortizatization of Intangibles declined to -$30000.0 in Q4 2025 per CUE's latest filing, from -$12000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $419.0 in Q4 2021 and troughed at -$220000.0 in Q4 2022.
• A 4-year average of -$73697.6 and a median of -$51500.0 in 2023 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles tumbled 52605.97% in 2022, then surged 88.12% in 2023.
• Over 4 years, Amortizatization of Intangibles stood at $419.0 in 2021, then sank by 52605.97% to -$220000.0 in 2022, then jumped by 94.55% to -$12000.0 in 2023, then slumped by 150.0% to -$30000.0 in 2025.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$30000.0, -$12000.0, and -$73000.0 for Q4 2025, Q3 2023, and Q2 2023 respectively.